Copyright
©The Author(s) 2019.
World J Meta-Anal. Aug 31, 2019; 7(8): 399-405
Published online Aug 31, 2019. doi: 10.13105/wjma.v7.i8.399
Published online Aug 31, 2019. doi: 10.13105/wjma.v7.i8.399
Study | Glycemic range | Ref. | Comments |
American College of Physicians | 140-200 mg/dL | Qaseem et al[17], 2014 | Recommend use of moderate glucose control to avoid hypoglycemic episodes |
American Diabetes Association | 140-180 mg/dL | American Diabetes Association[18], 2012 | Intensive insulin therapy in TGC can cause severe hypoglycemia |
Society of Critical Care Medicine | 150-180 mg/dL | Jacobi et al[19], 2012 | Recommend the use of moderate use of glucose control |
COIITSS study | 80-110 mg/dL | Annane et al[21], 2010 | No significant mortality in patients with TGC compared to MGC |
Standards of medical care in diabetes | Nondiabetic HbA1c < 7% 140-200 mg/dL HbA1c > 7% 160-220 mg/dL | Marik et al[22], 2014 | Different approach between diabetics and nondiabetics, due to glucose variability in tolerance |
- Citation: Casillas S, Jauregui E, Surani S, Varon J. Blood glucose control in the intensive care unit: Where is the data? World J Meta-Anal 2019; 7(8): 399-405
- URL: https://www.wjgnet.com/2308-3840/full/v7/i8/399.htm
- DOI: https://dx.doi.org/10.13105/wjma.v7.i8.399